Águeda Ancochea

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

Andrea Alemany, Pere Millat-Martínez, Marc Corbacho‐Monné et al. · The Lancet Respiratory Medicine · 2022 · 84 citations · Full text

Covid-19 Pandemic, Clinical Trials, Treatment Option +5

Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea

Alberto Álvarez‐Larrán, Luz Martínez‐Avilés, Juan Carlos Hernández‐Boluda et al. · Annals of Hematology · 2014 · 76 citations

Thrombosis, Polycythemia Vera, Essential Thrombocythemia Refractory +4

<scp>WHO</scp>‐histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes

Alberto Álvarez‐Larrán, Águeda Ancochea, M. García García et al. · British Journal of Haematology · 2014 · 65 citations

<i>JAK2</i>V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

Alberto Álvarez‐Larrán, Beatríz Bellosillo, Arturo Pereira et al. · American Journal of Hematology · 2014 · 48 citations · Full text

Essential Thrombocythemia, Myelofibrotic Transformation, Immunology +23

Fast-screening flow cytometry method for detecting nanoplastics in human peripheral blood

Roser Salvia, Laura G. Rico, Jolene A. Bradford et al. · MethodsX · 2023 · 45 citations · Full text